Thursday, November 19, 2009

Bristol Myers Squibb to pay 515 million to Settle Fraud Charges 2007 Melanoma..Jim Breitfeller

Shortage of Ipilimumab, I don't think so. I think it was staged to save and revert the drug to other Clinial trials. That is my opionion. Go to Clinical Trials. In the search field, type, Ipilimumab, Melanoma, protrate cancer, breast cancer,colon cancer, liver cancer. Then see when the trials that are recruiting and start date.

If it is after 8-12-2008, then the clinical trials was started with Ipilimumab after they took away compassionate drug use for the Melanoma Patients and is unethical to say the least.



Drugs giant Bristol-Meyers Squibb and a former subsidiary have been hauled over the coals and forced to pay more than half a billion dollars to settle settle federal and state investigations for promoting an anti-psychotic drug, Ablify, for uses that were not approved by the US Food and Drug Administration and providing illegal inducements to doctors and other health care providers.

The inducements included consulting fees and all expenses paid trips to resorts to attend conferences. There were also allegations that Bristol-Myers Squibb was behind the submission of false or fraudulent claims to medicaid, Medicare and other federal health programs.

Bristol Myers Squibb_pinged_515_million_to_settle_fraud_charges





Take Care,

Jimmy B
Photobucket

No comments:

Post a Comment